T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...

If successful, the result could be lower Medicare Part D prices for drugs used to create a variety of conditions, such as ...

Eli Lilly's stock tumbled 8% on Tuesday after it forecast fourth-quarter sales of weight-loss drug Zepbound below Wall Street ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent ...

A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues including dementia and cardiovascular diseases, although experts warned against seeing ...

Industry lobbyists maintain that this will reduce investment in new pill medications even if they may be the most effective and affordable option for patients. In addition to the weight-loss ...

The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...

Research reveals groundbreaking results about Mounjaro and Ozempic in weight loss treatment. Here's what you need to know ...

Diabetes and weight loss drugs Ozempic and Wegovy have been added to the list of medications selected for Medicare price ...

Since Wegovy’s FDA approval in 2021, Ozempic has often been prescribed ... Why Ozempic and New Weight-Loss Drugs Are Different The emergence of semaglutide has ushered in a new era of obesity ...

Semaglutide 7.2 mg significantly outperformed semaglutide 2.4 mg and placebo with a 20.7% average reduction in weight and a ...